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Introduction
============

Hand osteoarthritis (OA) is a common joint disease worldwide, resulting in weakened grip strength and significant functional disability \[[@B1]\]. As nonweight-bearing joints, the hand is a useful target for the study of nonmechanical risk factors for OA pathogenesis \[[@B2]-[@B10]\].

Obesity has been observed to have associations with OA development in nonweight-bearing joints as well as in weight-bearing joints \[[@B11]-[@B14]\]. Adipokine hormones such as leptin have long been thought to contribute to OA pathogenesis directly, independent of the mechanical effect of obesity \[[@B3],[@B4],[@B11],[@B15]\]. Leptin, a small polypeptide, is predominantly produced in white adipose tissue and regulates food intake and energy expenditure. Leptin has also been increasingly recognized to play a role in inflammation, angiogenesis, as well as cartilage and bone metabolism, and thus has been implicated in the development of osteoarthritis \[[@B3],[@B15]-[@B18]\].

Studies have suggested a possible relationship between leptin and OA of weight-bearing joints \[[@B15],[@B16]\]. However, there have been few studies of nonweight-bearing joints - such as the hand joints - to examine nonmechanical risk factors for OA. Leptin was not associated with hand OA progression in a recent study of fewer than 300 subjects \[[@B19]\]. To date, no study has examined the cross-sectional association between leptin and hand OA in a population-based sample. The objective of our study was to determine whether a cross-sectional relationship exists between leptin and OA in a US population-based sample of adults at least 60 years of age.

Materials and methods
=====================

Study sample
------------

We used data from the Third National Health and Nutrition Examination Survey (NHANES III), a national cross-sectional population-based survey conducted from 1988 to 1994 to assess the health and nutrition of the non-institutionalized US population. Survey data, which include demographics, health status, health disorders, and behaviors among others, were collected by household interviews. Physical examinations and blood draws were also performed by physicians at mobile examination centers. For this analysis we used data from the demographic file \[[@B20]\], the examination file \[[@B21]\], and the serum leptin file \[[@B22]\]. Our analysis was restricted to subjects surveyed from 1991 to 1994 and age 60 years or older because NHANES III conducted the hand examination only on these subjects.

NHANES III subjects were randomly assigned to be tested for leptin \[[@B22]\]. Subjects with rheumatoid arthritis were excluded from the analysis, based on clinical information collected at the physician interview, examination and criteria used by Dillon, Rasch and colleagues \[[@B23],[@B24]\]. Institutional Review Board approval was not necessary because the National Health and Nutrition Examination Survey is a publically available database.

Data elements
-------------

### Assessment of hand osteoarthritis

We applied a previously developed algorithm for defining hand OA in the National Health and Nutrition Examination Survey. Dillon and colleagues developed a definition of hand OA in the National Health and Nutrition Examination Survey database that is modeled on the American College of Rheumatology definition \[[@B23]\]. The American College of Rheumatology criteria and the NHANES III definition differ slightly, as shown in Table [1](#T1){ref-type="table"}\[[@B23]\]. We defined asymptomatic hand OA as cases fulfilling criteria 2 to 4 but not criterion 1. In the group without hand OA, subjects did not have symptoms or physical examination evidence of hand OA. Hand radiographs were not released from NHANES III for analysis.

###### 

Hand osteoarthritis classification criteria

  American College of Rheumatology criteria                           **Criteria for symptomatic hand OA using NHANES III data adapted from Dillon and colleagues**^**a**^
  ------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Hand OA is identified if participants meet criteria 1 to 4:         Hand OA is identified if participants meet criteria 1 to 4:
   1. Hand pain, aching, or stiffness                                  1. Ever had history of hand pain, aching, stiffness lasting more than 6 weeks
   2. Hard tissue enlargement of two or more of 10 selected joints     2. At least two sites of hard tissue enlargement, with the combination of first CMC and one other site with Heberden\'s or Bouchard\'s nodes
   3. Fewer than three swollen metacarpal-phalangeal joints            3. Fewer than three swollen metacarpal-phalangeal joints or participants do not meet the criteria for rheumatoid arthritis
   4a. Either hard tissue enlargement of two or more DIP joints, or    4. The presence of bilateral Heberden\'s nodes at any site
   4b. deformity of one out of 10 joints                               (would remove this number \"5\" as this is not one of the criteria used in Dillon\'s NHANES study. The text was put here to compare with ACR criteria. No such data available from NHANES III

CMC, carpometacarpal; DIP, distal interphalangeal joint; NHANES III, Third National Health and Nutrition Examination Survey. ^a^This is the classification used to define symptomatic hand osteoarthritis (OA) in the present study. Adapted from Dillon and colleagues \[[@B23]\].

### Leptin

Human studies have shown that leptin levels probably peak between 12 midnight and 2:30 am, and are lowest between noon and early afternoon \[[@B25]\]. In NHANES III, leptin was measured in the morning after an 8-hour overnight fast. Leptin has been shown to remain stable when stored frozen for many years \[[@B26]-[@B29]\]. The laboratory analysis for serum leptin was performed by Linco Research, Inc. (St. Louis, MO, USA) using a radioimmunoassay with a rabbit polyclonal antibody against highly purified recombinant human leptin. Detectable concentrations of the assay range from 0.5 to 100 fg/l. Within-assay and between-assay reliability coefficients of variations range from 3.4 to 8.3% for radioimmunoassay and from 3.6 to 6.2% for western blot \[[@B22]\].

### Potential confounders

We hypothesized that age, sex, race/ethnicity, body mass index (BMI), the presence of polyarticular OA, diabetes, and total cholesterol may confound the relationship between leptin and hand OA. We thus accounted for these variables in the analysis. Age was classified into three groups; 60 to 69 years, 70 to 79 years, and 80+ years. We classified a subject\'s race/ethnicity as non-Hispanic white, non-Hispanic black, Hispanic, or other. We classified BMI as normal (\< 25 kg/m^2^), overweight (25 to 29.99 kg/m^2^), and obese (≥ 30 kg/m^2^). Polyarticular OA was defined as the presence of radiographic knee OA with a Kellgren-Lawrence grade ≥ 2 in at least one knee in addition to having either symptomatic hand OA or asymptomatic hand OA. Total cholesterol was classified as desirable (\< 200), borderline high (200 to 239), and high (≥ 240).

Statistical analysis
--------------------

To ensure that the sample of subjects with a leptin measurement did not differ from the sample of subjects without a leptin measurement, we compared potential confounders for those with a leptin measurement and for those without a leptin measurement. The remaining analyses were performed on those with a hand examination and a leptin measurement. We calculated percentages by hand OA status for all potential confounders. We estimated unadjusted mean leptin levels by hand OA status and the other potential confounders stratified by sex. We stratified analyses of leptin by sex because the mean and variance of serum leptin concentration was much greater among females than in males. We further applied linear regression to estimate the adjusted mean leptin by hand OA status stratified by sex. To fit the most parsimonious model, we only included potential confounders in the final model if they reached statistical significance at an alpha level of 0.05. We used SAS statistical software (version 9.2; SAS Institute, Inc, Cary, North Carolina, U.S.A.) to perform all analyses. To account for the complex multistage survey design and to obtain estimates representative of the non-institutionalized US population, we used survey procedures within SAS and weighted the analyses using the appropriate survey sampling weight.

Results
=======

Of the 2,589 subjects who had interviews and hand examinations, examination data were complete in 2,498. Nineteen patients with rheumatoid arthritis were excluded. Of 2,477 subjects that were eligible for the analysis, 1,056 (42.6%) had a serum leptin measurement and comprised our sample. Subjects with leptin measurements and those who did not have leptin measurements were similar with respect to demographic factors (age, sex, race, BMI) (see Additional file [1](#S1){ref-type="supplementary-material"}). Among those in our final sample, hand OA was symptomatic in 90 patients (8.5%), asymptomatic in 376 patients (35.6%), and not present in 590 patients (55.9%).

The mean age of the final sample was 70.3 ± 8.2 years and the mean BMI of the final sample was 26.4 ± 4.9 kg/m^2^. Subjects with hand OA (both symptomatic and asymptomatic) were more likely to be female than those without hand OA. Subjects with symptomatic hand OA were more likely to be overweight (45%) and obese (25%) than those with asymptomatic hand OA (39% overweight and 16% obese). Detailed data on the demographic and clinical characteristics of our sample stratified by hand OA status are shown in Table [2](#T2){ref-type="table"}.

###### 

Demographic characteristics of the sample by hand osteoarthritis status

                                         Symptomatic hand OA   Asymptomatic hand OA   No hand OA
  -------------------------------------- --------------------- ---------------------- ------------
  Age                                                                                 
   60 to 69 years                        41 (45%)              138 (45%)              309 (58%)
   70 to 79 years                        35 (46%)              140 (39%)              169 (28%)
   80+ years                             14 (9%)               98 (17%)               112 (15%)
  Sex                                                                                 
   Male                                  36 (34%)              159 (37%)              315 (49%)
   Female                                54 (66%)              217 (63%)              275 (51%)
  Race/ethnicity                                                                      
   Non-Hispanic white                    47 (85%)              251 (90%)              301 (79%)
   Non-Hispanic black                    17 (9%)               49 (5%)                124 (8%)
   Hispanic                              26 (5%)               75 (5%)                153 (9%)
   Other                                 0 (0%)                1 (0%)                 12 (4%)
  BMI status                                                                          
   Normal (BMI \< 25 kg/m^2^)            22 (31%)              152 (45%)              208 (42%)
   Overweight (25 ≤ BMI \< 30 kg/m^2^)   39 (45%)              145 (39%)              212 (35%)
   Obese (BMI ≥ 30 kg/m^2^)              25 (25%)              50 (16%)               133 (23%)
  Radiographic knee OA                                                                
   Yes                                   36 (31%)              130 (32%)              177 (30%)
   No                                    47 (69%)              234 (68%)              391 (70%)
  Diabetes                                                                            
   Yes                                   19 (15%)              36 (8%)                81 (11%)
   No                                    71 (85%)              339 (92%)              508 (89%)
  Total cholesterol                                                                   
   Desirable (\< 200)                    27 (26%)              120 (27%)              190 (29%)
   Borderline high (200 to 239)          32 (39%)              140 (40%)              218 (39%)
   High (≥ 240)                          31 (35%)              113 (32%)              173 (32%)

Data presented as *n*(%). Percentages are weighted using Third National Health and Nutrition Examination Survey sampling weights. BMI, body mass index; OA, osteoarthritis.

Unadjusted mean leptin levels stratified by sex and all potential confounders are shown in Table [3](#T3){ref-type="table"}. Among males, the unadjusted mean leptin level did not vary substantially by hand OA status. Those with no hand OA had a mean leptin of 8.22 (95% confidence interval (CI) = 7.47, 8.97) compared with 7.38 (95% CI = 5.31, 9.46) for those with symptomatic hand OA and 6.69 (95% CI = 5.19, 8.18) for those with asymptomatic hand OA. Among females, the unadjusted mean leptin did vary slightly by hand OA status, with those with asymptomatic hand OA having the lowest mean leptin at 17.09 (95% CI = 15.00, 19.18). However, all of the 95% CIs overlapped. The mean leptin for females with symptomatic hand OA was 21.55 (95% CI = 17.08, 26.02) and for no hand OA was 20.77 (95% CI = 18.01, 23.53). Mean leptin levels increased as BMI increased for both males and females.

###### 

Unadjusted mean leptin by sex for hand osteoarthritis status and potential confounders in NHANES III

                                         Male   Female                       
  -------------------------------------- ------ ---------------------- ----- ----------------------
  Overall                                510    7.66 (7.11, 8.21)      546   19.24 (17.19, 21.29)
  Hand OA status                                                             
   Symptomatic hand OA                   36     7.38 (5.31, 9.46)      54    21.55 (17.08, 26.02)
   Asymptomatic hand OA                  159    6.69 (5.19, 8.18)      217   17.09 (15.00, 19.18)
   No hand OA                            315    8.22 (7.47, 8.97)      275   20.77 (18.01, 23.53)
  Age                                                                        
   60 to 69 years                        255    7.53 (6.83, 8.22)      233   21.43 (18.73, 24.13)
   70 to 79 years                        147    7.88 (6.47, 9.29)      197   17.60 (14.47, 20.73)
   80+ years                             108    7.66 (6.24, 9.07)      116   16.00 (12.73, 19.28)
  Race/ethnicity                                                             
   Non-Hispanic white                    273    7.62 (7.06, 8.17)      326   18.73 (16.52, 20.95)
   Non-Hispanic black                    89     7.30 (5.61, 8.99)      101   24.39 (21.52, 27.25)
   Hispanic                              139    8.74 (6.24, 11.25)     115   19.34 (13.94, 24.74)
   Other                                 9      7.42 (6.31, 8.53)      4     19.83 (-2.88, 42.54)
  BMI status                                                                 
   Normal (BMI \< 25 kg/m^2^)            183    5.00 (4.30, 5.70)      199   11.54 (10.30, 12.77)
   Overweight (25 ≤ BMI \< 30 kg/m^2^)   217    7.73 (6.75, 8.70)      179   19.65 (17.68, 21.63)
   Obese (BMI ≥ 30 kg/m^2^)              90     13.03 (11.03, 15.03)   118   34.55 (31.22, 37.88)
  Radiographic knee OA                                                       
   Yes                                   132    8.99 (7.53, 10.45)     211   23.31 (19.55, 27.08)
   No                                    357    7.09 (6.59, 7.60)      315   16.93 (14.99, 18.87)
  Diabetes                                                                   
   Yes                                   64     8.69 (7.10, 10.27)     72    20.62 (16.47, 24.76)
   No                                    445    7.55 (7.02, 8.08)      473   19.1 (17.13, 21.08)
  Total cholesterol                                                          
   Desirable (\< 200)                    201    7.24 (6.33, 8.14)      136   14.87 (12.01, 17.73)
   Borderline high (200 to 239)          193    7.36 (6.66, 8.07)      197   18.99 (16.40, 21.58)
   High (≥ 240)                          113    8.18 (6.92, 9.44)      204   22.20 (18.99, 25.41)

BMI, body mass index; CI, confidence interval; OA, osteoarthritis. ^a^Means are weighted using Third National Health and Nutrition Examination Survey (NHANES III) sampling weights.

Results of the linear regression showed similar findings to the unadjusted analysis. The final model included hand OA status, age, and obesity status. Race/ethnicity, diabetes, polyarticular OA, and total cholesterol were not included in the final model. Among males, the adjusted mean leptin for those with symptomatic hand OA was 8.88 (95% CI = 7.08, 10.67) compared with 8.21 (95% CI = 6.62, 9.80) for those with asymptomatic hand OA and 9.40 (95% CI = 8.59, 10.21) for those with no hand OA. Similarly, among females, the adjusted mean leptin for those with symptomatic hand OA was 21.89 (95% CI = 18.70, 25.07) compared with 20.13 (95% CI = 18.32, 21.95) for those with asymptomatic hand OA and 23.09 (95% CI = 21.83, 24.34) for those with no hand OA (Table [4](#T4){ref-type="table"}). None of these differences in adjusted mean leptin levels was statistically significant (all *P*\> 0.05).

###### 

Adjusted mean leptin by sex and hand osteoarthritis status

                         Male   Female                
  ---------------------- ------ ------------- ------- --------------
  Symptomatic hand OA    8.88   7.09, 10.67   21.89   18.70, 25.08
  Asymptomatic hand OA   8.21   6.62, 9.80    20.13   18.32, 21.94
  No hand OA             9.40   8.59, 10.21   23.09   21.84, 24.34

CI, confidence interval; OA, osteoarthritis. ^a^Means are adjusted for age and obesity status, and are weighted using Third National Health and Nutrition Examination Survey sampling weights.

Discussion
==========

The present study used data from NHANES III to describe the cross-sectional relationship between leptin and hand OA. The study did not provide evidence to support the hypothesis that hand OA is associated with increased serum leptin level. Stratified and multivariable analyses did not show evidence of a difference in leptin levels in the symptomatic hand OA, asymptomatic hand OA, and no hand OA groups. The multivariable analyses adjusted for age, race/ethnicity, BMI status, and the presence of polyarticular OA as indicated by radiographic knee OA, diabetes status, and serum cholesterol.

Our analyses have several important strengths. NHANES III has a large sample size, making it unlikely that we simply missed an effect due to chance. Also, selection bias is unlikely because the NHANES III sample was representative of the US population. Lastly, since we accounted for the complex sample design and used the sampling weights, the estimates are representative of the US population \[[@B22]\].

The study also has limitations. A possible explanation for our null result is that the association between hand OA and leptin is complex and cannot be assessed using a cross-sectional sample. Leptin may be associated with hand OA at one time point of its development only. However, in the longitudinal study carried out by Yusuf and colleagues, serum leptin was not found to be associated with hand OA progression in 6-year follow-up of 248 participants \[[@B19]\]. The paper by Yusuf and colleagues used a longitudinal design with a radiographic case definition \[[@B19]\]. In the present cross-sectional study, we measured hand OA by an algorithm that incorporates symptoms and physical examination. These two approaches are complementary, and neither supports an association between serum leptin and hand OA.

Another explanation for the null result is the possible misclassification of hand OA in NHANES III. There is no gold standard for the diagnosis of hand OA. Our use of the classification criteria suggested by Dillon and colleagues could have resulted in misclassification. Many patients with early or developing OA start with pain, followed by delayed onset of bony enlargement for months or years. Using our criteria, these subjects would be categorized as having no OA. Misclassification of this sort would tend to bias associations toward the null and could indeed play a role in our negative findings.

As expected, our results confirmed that leptin is associated with gender and BMI status, consistent with prior animal and human studies \[[@B30]-[@B33]\]. These findings provide face validity for the leptin measurements. Our study is the largest population-based confirmation of such a relationship in humans, with prior studies in the literature having sample sizes ranging from 87 to 426 subjects \[[@B30]-[@B33]\].

Conclusions
===========

We did not find a cross-sectional association between hand OA and serum leptin in our sample. Prospective studies are needed to further evaluate the possibility that elevated leptin levels predate the onset or progression of clinically apparent hand OA.
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